Xvivo Perfusion AB (XVIVO) — Cash Flow-to-Debt Ratio
Xvivo Perfusion AB (XVIVO) has a Cash Flow-to-Debt Ratio of 0.19x as of June 2026, meaning its operating cash flow of Skr63.49 Million could theoretically repay 0% of its total liabilities (Skr326.64 Million) in one year. See financial agility of Xvivo Perfusion AB to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xvivo Perfusion AB Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Xvivo Perfusion AB across 15 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Xvivo Perfusion AB.
Annual Cash Flow-to-Debt Ratio for Xvivo Perfusion AB (2011–2025)
Year-by-year debt coverage analysis for Xvivo Perfusion AB. Check cash flow quality index of Xvivo Perfusion AB to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | Skr101.07 Million | Skr260.65 Million | ▼ -14.3% |
| 2024 | 0.45x | Skr111.29 Million | Skr245.97 Million | ▲ +144.9% |
| 2023 | 0.18x | Skr46.29 Million | Skr250.57 Million | ▲ +100.9% |
| 2022 | 0.09x | Skr27.86 Million | Skr302.95 Million | ▲ +296.1% |
| 2021 | -0.05x | Skr-12.06 Million | Skr257.15 Million | ▲ +45.8% |
| 2020 | -0.09x | Skr-12.27 Million | Skr141.85 Million | ▼ -116.7% |
| 2019 | 0.52x | Skr29.50 Million | Skr56.97 Million | ▲ +1.1% |
| 2018 | 0.51x | Skr23.63 Million | Skr46.13 Million | ▼ -21.1% |
| 2017 | 0.65x | Skr22.19 Million | Skr34.21 Million | ▲ +70.0% |
| 2016 | 0.38x | Skr12.55 Million | Skr32.88 Million | ▼ -14.1% |
| 2015 | 0.44x | Skr8.58 Million | Skr19.31 Million | ▲ +403.1% |
| 2014 | -0.15x | Skr-3.74 Million | Skr25.52 Million | ▼ -133.7% |
| 2013 | 0.44x | Skr13.46 Million | Skr30.93 Million | ▲ +571.7% |
| 2012 | 0.06x | Skr1.67 Million | Skr25.75 Million | ▼ -41.0% |
| 2011 | 0.11x | Skr14.17 Million | Skr128.97 Million | — |